New scan seeks to uncover hidden brain inflammation in long COVID sufferers

NCT ID NCT06920628

First seen Jun 27, 2026 · Last updated Jul 08, 2026 · Updated 2 times

Summary

This study is testing whether a radioactive tracer called 11C-PS13 can detect brain inflammation in people who have long-term neurological symptoms after COVID-19. Researchers will compare PET scans from 60 adults (both healthy volunteers and those with long COVID) to see if the tracer highlights areas of inflammation. The goal is to better understand the biology behind brain fog, headaches, and other post-COVID brain issues.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
11C-PS13 (a radioactive tracer injected before a PET scan)
What this could lead to
If successful, this could help identify a biological marker for brain inflammation in long COVID, pointing toward new ways to diagnose or treat these symptoms.
What could go wrong
This is a very early Phase 1 study with only 60 participants. It is designed to measure inflammation, not to test a treatment, so it may not lead directly to any therapy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LONG COVID are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Inflammation long COVID-19

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • National Institutes of Health Clinical Center

    RECRUITING

    Bethesda, Maryland, 20892, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.